Management of liver metastases secondary to thymic epithelial tumors: a narrative review of current management and future directions
Authors:
- Alex J. MaAMAlex J. Ma
- Erica S. AlexanderEAErica S. Alexander
Open Access
- 1 March 2026
- journal article
- review article
- Published by AME Publishing Company in Mediastinum
- Vol. 10, 1
Abstract
Background and Objective: Hepatic metastases secondary to thymic epithelial tumors (TETs), encompassing thymomas and thymic carcinomas (TCs), are a rare but clinically meaningful phenomenon and are associated with worse overall survival (OS). Management of liver metastases is largely limited to systemic therapy and chemotherapeutic regimens; although, there are smaller-scale studies in the literature reporting use of more novel treatment regimens and liver-directed therapies. The purpose of this article is to explore management options for TET hepatic metastases, including novel therapeutic options. Methods: A review of the available electronic literature was performed through October 10, 2025, using PubMed and Google Scholar. A single author identified the studies, and both authors reviewed the selection to determine which studies to include. Key Content and Findings: The literature involving systemic therapy options was much more developed, as this is the first-line treatment option for TET hepatic metastases. Smaller series supporting the use of surgical resection, radiation therapy, and interventional radiology therapies suggest benefit in liver-directed resection and/or therapies. Conclusions: Data evaluating therapeutic options for managing liver metastases secondary to TETs is limited. Given the prognostic implications of these metastatic lesions, a broader understanding of available therapies is essential for determining optimal management.Keywords
This publication has 84 references indexed in Scilit:
- THYMOMA METASTASIZING TO EXTRATHORACIC SITESActa Pathologica Microbiologica Scandinavica Section A Pathology, 2009
- Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapyEuropean Journal of Cancer, 2008
- Thymic tumorsThe Annals of Thoracic Surgery, 2004
- Octreotide Alone or With Prednisone in Patients With Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II TrialJournal of Clinical Oncology, 2004
- Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from JapanThe Annals of Thoracic Surgery, 2003
- Thymic basaloid carcinoma with hepatic metastasisThe Annals of Thoracic Surgery, 2002
- Treatment of Invasive Thymoma With Single-Agent IfosfamideJournal of Clinical Oncology, 1999
- Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.Journal of Clinical Oncology, 1994
- Malignant Thymoma with Distant Metastases: A Case Report and Review of the LiteratureJapanese Journal of Clinical Oncology, 1983
- Malignant thymoma associated with myasthenia gravis, and evidence of extrathoracic metastases.An analysis of published cases and report of a caseCancer, 1971